Cargando…
mTORC1-Dependent Protein and Parkinson’s Disease: A Mendelian Randomization Study
Background: The mTOR pathway is crucial in controlling the growth, differentiation, and survival of neurons, and its pharmacological targeting has promising potential as a treatment for Parkinson’s disease. However, the function of mTORC1 downstream proteins, such as RPS6K, EIF4EBP, EIF-4E, EIF-4G,...
Autores principales: | Tan, Cheng, Ai, Jianzhong, Zhu, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137243/ https://www.ncbi.nlm.nih.gov/pubmed/37190500 http://dx.doi.org/10.3390/brainsci13040536 |
Ejemplares similares
-
Association of mTORC1‑dependent circulating protein levels with cataract formation: a mendelian randomization study
por: Cai, Yingjun, et al.
Publicado: (2022) -
mTORC1 Dependent Regulation of REDD1 Protein Stability
por: Tan, Chia Yee, et al.
Publicado: (2013) -
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
Hyperactivity of mTORC1 or mTORC2-dependent signaling causes epilepsy downstream of somatic PTEN loss
por: Cullen, Erin R., et al.
Publicado: (2023)